It's time to bring generic drug manufacturing back to the U.S. - STAT

Repatriating generic drug manufacturing would avert drug shortages, preserve the integrity of generic drugs, and create thousands of high-quality U.S. jobs.

Prescription Drug Policy, 2021 And 2022: The Year In Review, And

U.S. Consumers Overpay for Generic Drugs – USC Schaeffer

Research and Development in the Pharmaceutical Industry

The Paths to Value for US Generics

Reshoring Pharmaceutical Manufacturing to the US: Can We Do It?

Who Makes This Drug? Disclosing The Identity Of Generic Drug

The US is underutilizing its manufacturing capacity: report

How the coronavirus explosed US' reliance on India and China for

House Hearing on the Generic Drug Supply

Generic Drug Regulation and Pharmaceutical Price-Jacking

It's Time for Public Pharma - The American Prospect

Mark Cuban's Cost Plus Drug Company offers discounted drugs, but

How U.S. drugmaker Akorn's closure contributed to the escalating